The following IPOs are expected to price this week:
Chesapeake Granite Wash Trust (CHKR), which owns royalty interests in established and horizontal development wells in western Oklahoma, plans to raise $468 million by offering 23.4 million shares at a price range of $19 to $21. At the mid-point of the proposed range, Chesapeake Granite Wash Trust will command a market value of $935 million. The Austin, TX-based company plans to list on the NYSE under the symbol CHKR. Morgan Stanley and Raymond James are the lead underwriters on the deal.
HomeStreet (HMST), a full-service community bank operating primarily in the Pacific Northwest, plans to raise $165 million by offering 7.2 million shares at a price range of $22 to $24. At the mid-point of the proposed range, HomeStreet will command a market value of $214 million. HomeStreet, which was founded in 1921, booked $49 million in sales over the last 12 months. The Seattle, WA-based company plans to list on the NASDAQ under the symbol HMST. FBR Capital Markets is the lead underwriter on the deal. HomeStreet had originally planned to go public in August, before postponing due to market conditions.
Imperva (IMPV), which offers database, file and web application solutions to protect data in data centers, plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the mid-point of the proposed range, Imperva will command a market value of $366 million. Imperva, which was founded in 2002, booked $72 million in sales over the last 12 months. The Redwood Shores, CA-based company plans to list on the NYSE under the symbol IMPV. J.P. Morgan and Deutsche Bank Securities are the lead underwriters on the deal.
LRR Energy, L.P. (LRE), an LP formed by Lime Rock Resources to develop oil and natural gas properties in North America, plans to raise $188 million by offering 9.4 million shares at a price range of $19 to $21. At the mid-point of the proposed range, LRR Energy, L.P. will command a market value of $448 million. LRR Energy, L.P., which was founded in 2011, booked $117 million in sales over the last 12 months. The Houston, TX-based company plans to list on the NYSE under the symbol LRE. Wells Fargo Securities, Raymond James, and Citi are the lead underwriters on the deal.
NewLink Genetics (NLNK), which is developing a Phase 3 drug for surgically-resected pancreatic cancer patients, plans to raise $61 million by offering 5.5 million shares at a price range of $10 to $12. At the mid-point of the proposed range, NewLink Genetics will command a market value of $223 million. NewLink Genetics, which was founded in 1999, booked $2 million in sales over the last 12 months. The Ames, IA-based company plans to list on the NASDAQ under the symbol NLNK. Stifel Nicolaus Weisel, Canaccord Genuity, and Baird are the lead underwriters on the deal.
Renaissance Capital will have Pre-IPO Research available on these upcoming IPOs prior to its pricing.
Last week, there were 3 IPO pricings. Groupon (GRPN), which is leading e-commerce site used by merchants to offer customers daily discounts, was the week's winner, ending up 31% from its IPO price.
